Sign in
WithdrawnNo phase

Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP

Key facts

Who runs it
Aktiia SA
Where
Portland, United StatesSee the site
Trial code
Status
Withdrawn
Started
15 Dec 2024
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Aktiia Device
  • Upper arm cuff
Record updated
18 February 2025
Why it stopped
Study aborted by the sponsor

Who can take part

Age
21 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 38 criteriaShow less

Who can take part

  • Age 21-80 years old
  • Owns a smartphone that is an Android or iOS with a data plan
  • Fluent in written and spoken English as the technology is currently only available in English
  • Average of 3 BP readings in last 18 months of >140/90 OR last in-office BP >140/90 in the last 6 months as documented in their Electronic Health Record
  • Is a patient with Providence Health
  • Willing to attend the 2 in-person study visits
  • Is not participating in another study that is designed to influence blood pressure
  • Willing to wear the Aktiia bracelet for 6 months
  • Willing to be randomized to either group
  • Had a BMP in the last 12 months or is willing to get one at the discretion of the clinical pharmacist as standard of care

Who cannot take part

  • Currently undergoing or will undergo active IV infusions for chemotherapy
  • Tachycardia (heart rate at rest > 120bpm)
  • Diabetes Mellitus
  • Raynaud's disease
  • Arteriovenous fistula
  • Exfoliative skin disease
  • Known allergy to silicone
  • Terminal medical condition with a life expectancy less than 2 years
  • Diagnosed whitecoat hypertension
  • Any condition which, at the discretion of the enrolling investigator, would preclude their ability to comply with study procedures
  • Cardiomyopathy with LVEF <40% documented within the past year
  • CKD 4-5 (eGFR ≤ 30 mL/min)
  • Blood pressure at the baseline in-office visit is too low (SBP <140 mmHg AND DBP <90 mmHg) OR is too high (SBP > 190 mmHg OR DBP > 120 mmHg)
  • Atrial fibrillation, persistent or chronic
  • Under active treatment for hyperthyroidism
  • Myxedema coma
  • Subclavian stenosis
  • Pheochromocytoma
  • Trembling and shivering
  • Known pregnancy
  • Breastfeeding
  • Arm amputation
  • Lymphedema
  • Upper arm circumference < 22 cm or > 42 cm
  • Wrist circumference < 14 cm or > 21 cm
  • Adults unable to consent or who need a legally authorized representative to consent
  • Currently incarcerated or detained in accordance with federal regulations regarding prisoners (e.g., 45 CFR 46 Subpart C)
  • On hospice or going on hospice in the next 6-months

Where in United States

  • Providence Health & ServicesPortland, United States

About the trial

What the trial wants to find out

The purpose of the CHANGE-BP study is to examine the change in in-office measured Blood Pressure (BP) from baseline to end of study (6-months) between participants randomized to either 1) Continual Blood Pressure Monitoring (CBPM), which includes receiving Aktiia's novel cuffless BP Research System that has an accompanying Aktiia Patient Interface smartphone application, and care delivered through a centralized Aktiia Provider Interface that displays device data and is accessible by a health care professional or 2) Home Blood Pressure Monitoring (HBPM), which includes a standard oscillometric blood pressure cuff and the standard blood pressure management care from a participant's primary care physician.

The 2 groups in the trial

  • Continuous Blood Pressure Monitoring (CBPM)Treatment being tested

    Participants will wear the Aktiia Bracelet for 6-months and potentially receive blood pressure medication titrations during the 6-month period.

    Treatment: Aktiia Device

  • Home Blood Pressure Monitoring (HBPM)Existing treatment, for comparison

    Participants will receive an upper arm cuff and standard hypertension care from their primary care physician.

    Treatment: Upper arm cuff

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
18 February 2025